Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vedolizumab Safety and Efficacy in Indian Patients with UC and CD
NCT04804540Phase 4Completed
- Sponsor
- Takeda
- Start
- Dec 2021
- Primary completion
- Feb 2024
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of vedolizumab in ulcerative colitis (UC), Crohn's disease, sponsored by Takeda. Started Dec 2021; status: completed.
02
Drugs
vedolizumab
03
Conditions
ulcerative colitis (UC)Crohn's disease
Beyond the preview
Go deeper on NCT04804540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04804540.